Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Pfizer's Parkinson's Drugs Will Be Developed by Start-up Cerevel Therapeutics

    Pfizer's Parkinson's Drugs Will Be Developed by Start-up Cerevel Therapeutics

    Cerevel Therapeutics gains preclinical and clinical-stage drugs from Pfizer's previous neuroscience program.
    Learn more
  • Apply for Free Liftware Stabilizing Spoon

    Apply for Free Liftware Stabilizing Spoon

    The Uplift Program connects people with hand tremor to Liftware Steady, a stabilizing handle with eating attachments that makes it easier to enjoy meals.
    Learn more
  • Clinical Trial of Parkinson's Immunotherapy Now Recruiting

    Clinical Trial of Parkinson's Immunotherapy Now Recruiting

    The Phase II trial is recruiting people with PD ages 40 to 80 to test a drug that targets alpha-synuclein.
    Learn more
  • Two New Parkinson's Drugs Approaching Market: FDA Set to Rule on Novel Treatments Funded by MJFF in Early Development

    Two New Parkinson's Drugs Approaching Market: FDA Set to Rule on Novel Treatments Funded by MJFF in Early Development

    The FDA is expected to rule on these two therapies in January 2019. An approval would mark a milestone in MJFF's 'de-risking' strategy.
    Learn more
  • A Note from Our CEO: A Comprehensive Approach to Parkinson's

    A Note from Our CEO: A Comprehensive Approach to Parkinson's

    MJFF works to understand the full scope of resources that Parkinson's researchers need and help provide them.
    Learn more
  • Nicotine Patch Not Beneficial in Parkinson's

    Nicotine Patch Not Beneficial in Parkinson's

    A recent MJFF-supported study found that nicotine patches do not slow progression in people with early, untreated Parkinson's disease.
    Learn more
  • Patients and Providers Report Experiences with Rytary

    Patients and Providers Report Experiences with Rytary

    An MJFF survey evaluated patients' and clinicians' perspectives on and experiences with Rytary in the "real world," outside of clinical trials.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.